(Q48886646)

16 February 2018

title

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? (English)

1 reference

16 February 2018

0 references

4

David Y Graham

1 reference

16 February 2018

Ping I Hsu

1

1 reference

16 February 2018

Deng-Chyang Wu

series ordinal

2

1 reference

16 February 2018

Jeng-Yih Wu

series ordinal

3

1 reference

16 February 2018

publication date

1 April 2011

1 reference

16 February 2018

published in

Helicobacter

1 reference

16 February 2018

volume

16

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

146-152

1 reference

16 February 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Helicobacter pylori eradication therapy research: Ethical issues and description of results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Efficient identification and evaluation of effective Helicobacter pylori therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00829.X

10.1111/J.1523-5378.2011.00829.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

release_q42vzfxnjrbq5ofeca2ldjl2qq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q42vzfxnjrbq5ofeca2ldjl2qq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21435093

1 reference

16 February 2018